[Control measures for a VRE outbreak in a haemodialysis unit].
We report an outbreak of colonization with Vancomycin Resistant Enterococci (VRE) in the Haemodialysis unit of our hospital. From October 2004 to September 2008, 19 patients were found positive. The risk of acquiring this multi-resistant bacterium is extremely important in patients undergoing haemodialysis, heightened measures have gradually been set to control cross transmissions: first isolation, then geographic clustering of carriers and finally creating cohorting sectors with different staff for carriers, contacts and VRE free patients. This re-organization was supplemented by strengthening procedures for hand hygiene, active screening of patients and enhanced cleaning. Monitoring of the epidemic curve has allowed us to demonstrate the effectiveness of measures introduced. However, deleterious effects were observed in patients whose habits were changed; we could also highlight significant impact on the activity of the unit.
Diguio
N
N
Service d'Hygiène Hospitalière, Hôpital Brabois Adultes, CHU de Nancy, Rue du Morvan, 54 511, Vandoeuvre-les-Nancy cedex, France. n.diguio@chu-nancy.fr
Chanet
P
P
Hautemanière
A
A
Cao-Huu
T
T
Hartemann
P
P
Kessler
M
M
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D002353:Carrier State / Q000517:prevention & control; D003428:Cross Infection / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology / Q000517:prevention & control*; D004196:Disease Outbreaks / Q000517:prevention & control*; D004203:Disinfection / Q000379:methods; D016984:Enterococcus faecium / Q000302:isolation & purification; D004866:Equipment Contamination / Q000517:prevention & control; D005602:France; D016908:Gram-Positive Bacterial Infections / Q000150:complications / Q000188:drug therapy / Q000453:epidemiology / Q000517:prevention & control*; D006436:Hemodialysis Units, Hospital; D006801:Humans; D010356:Patient Isolation; D011481:Protective Clothing; D012189:Retrospective Studies; D014640:Vancomycin / Q000494:pharmacology / Q000627:therapeutic use; D020713:Vancomycin Resistance
D000900:Anti-Bacterial Agents; D014640:Vancomycin